Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expression. | Neurooncol Adv | 2021 | 33532725 | PubTator, text mining | PubMed |
| Micro/nanodevices for assessment and treatment in stomatology and ophthalmology. | Microsyst Nanoeng | 2021 | 33532080 | PubTator, text mining | PubMed |
| Fragmentation of Small-Cell Lung Cancer Regulatory States in Heterotypic Microenvironments. | Cancer Res | 2021 | 33531375 | PubTator, text mining | PubMed |
| Transcriptomic Signatures and Upstream Regulation in Human Skeletal Muscle Adapted to Disuse and Aerobic Exercise. | Int J Mol Sci | 2021 | 33530535 | PubTator, text mining | PubMed |
| Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer. | Sci Adv | 2021 | 33523897 | PubTator, text mining | PubMed |
| Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. | J Pers Med | 2021 | 33513899 | PubTator, text mining | PubMed |
| Glycolytic pathway candidate markers in the prognosis of oral squamous cell carcinoma: a systematic review with meta-analysis. | Braz J Med Biol Res | 2021 | 33503201 | PubTator, text mining | PubMed |
| Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression. | Cancer Res | 2021 | 33500247 | PubTator, text mining | PubMed |
| A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer. | J Exp Clin Cancer Res | 2021 | 33499877 | PubTator, text mining | PubMed |
| Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma. | Cancers (Basel) | 2021 | 33494394 | PubTator, text mining | PubMed |
| Risk assessment analysis for maternal autoantibody-related autism (MAR-ASD): a subtype of autism. | Mol Psychiatry | 2021 | 33483694 | PubTator, text mining | PubMed |
| miR-335-5p suppresses gastric cancer progression by targeting MAPK10. | Cancer Cell Int | 2021 | 33482821 | PubTator, text mining | PubMed |
| Personalized Genome-Scale Metabolic Models Identify Targets of Redox Metabolism in Radiation-Resistant Tumors. | Cell Syst | 2021 | 33476554 | PubTator, text mining | PubMed |
| Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives. | J Pers Med | 2021 | 33467153 | PubTator, text mining | PubMed |
| Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming. | Cancers (Basel) | 2021 | 33467031 | PubTator, text mining | PubMed |
| Metabolome-Driven Regulation of Adenovirus-Induced Cell Death. | Int J Mol Sci | 2021 | 33466472 | PubTator, text mining | PubMed |
| A novel and facile green synthesis method to prepare LDH/MOF nanocomposite for removal of Cd(II) and Pb(II). | Sci Rep | 2021 | 33452374 | PubTator, text mining | PubMed |
| Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. | Mol Cancer | 2021 | 33451333 | PubTator, text mining | PubMed |
| Deep muscle-proteomic analysis of freeze-dried human muscle biopsies reveals fiber type-specific adaptations to exercise training. | Nat Commun | 2021 | 33436631 | PubTator, text mining | PubMed |
| Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. | Signal Transduct Target Ther | 2021 | 33436555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=64